This protocol is judged by an institutional critique board, an independent group that opinions any clinical trials involving individuals. If a review includes a Routine I drug, after the board approves the protocol as ethical, the researchers have to make an application for an investigational new drug (IND) number from your FDA.“It’s imperativ